Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies. 1985

M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell

In a comparative study of antinuclear antibodies (ANA) and immune complexes in the serum of 43 patients with systemic sclerosis (SS) ANA were detected by indirect immunofluorescence on Hep 2 cells and/or double immunodiffusion in 90% of patients, while immune complex assays were positive in 32% of patients. The immune complex assays were positive only in sera containing antibodies to Scl 70, n-RNP, Ro, and La. The presence of immune complexes in SS sera is therefore related to ANA specificity. This might explain the variable findings of several previous studies of immune complexes in SS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
November 1967, The Journal of laboratory and clinical medicine,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
June 1984, Clinical and experimental immunology,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
August 1967, Der Nervenarzt,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
October 1964, Sabouraudia,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
October 1982, Arthritis and rheumatism,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
October 1982, Arthritis and rheumatism,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
January 2004, Archivum immunologiae et therapiae experimentalis,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
May 1979, Arthritis and rheumatism,
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
April 1987, Journal of immunology (Baltimore, Md. : 1950),
M A French, and G Harrison, and C A Penning, and J Cunningham, and P Hughes, and N R Rowell
April 1974, Lancet (London, England),
Copied contents to your clipboard!